Unknown

Dataset Information

0

Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.


ABSTRACT: We have designed bispecific antibodies that bind one target (anti-Her3) in a bivalent IgG-like manner and contain one additional binding entity (anti-cMet) composed of one V(H) and one V(L) domain connected by a disulfide bond. The molecules are assembled by fusing a V(H,Cys44) domain via flexible connector peptides to the C-terminus of one H-chain (heavy chain), and a V(L,Cys100) to another H-chain. To ensure heterodimerization during expression in mammalian cells, we introduced complementary knobs-into-holes mutations into the different H-chains. The IgG-shaped trivalent molecules carry as third binding entity one disulfide-stabilized Fv (dsFv) without a linker between V(H) and V(L). Tethering the V(H) and V(L) domains at the C-terminus of the C(H)3 domain decreases the on-rates of the dsFv to target antigens without affecting off-rates. Steric hindrance resolves upon removal of one side of the double connection by proteolysis: this improves flexibility and accessibility of the dsFv and fully restores antigen access and affinity. This technology has multiple applications: (i) in cases where single-chain linkers are not desired, dsFvs without linkers can be generated by addition of furin site(s) in the connector that are processed during expression within mammalian cells; (ii) highly active (toxic) entities which affect expression can be produced as inactive dsFvs and subsequently be activated (e.g. via PreScission cleavage) during purification; (iii) entities can be generated which are targeted by the unrestricted binding entity and can be activated by proteases in target tissues. For example, Her3-binding molecules containing linkers with recognition sequences for matrix metalloproteases or urokinase, whose inactivated cMet binding site is activated by proteolytic processing.

SUBMITTER: Metz S 

PROVIDER: S-EPMC3449404 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.

Metz Silke S   Panke Christian C   Haas Alexander K AK   Schanzer Jürgen J   Lau Wilma W   Croasdale Rebecca R   Hoffmann Eike E   Schneider Britta B   Auer Johannes J   Gassner Christian C   Bossenmaier Birgit B   Umana Pablo P   Sustmann Claudio C   Brinkmann Ulrich U  

Protein engineering, design & selection : PEDS 20120913 10


We have designed bispecific antibodies that bind one target (anti-Her3) in a bivalent IgG-like manner and contain one additional binding entity (anti-cMet) composed of one V(H) and one V(L) domain connected by a disulfide bond. The molecules are assembled by fusing a V(H,Cys44) domain via flexible connector peptides to the C-terminus of one H-chain (heavy chain), and a V(L,Cys100) to another H-chain. To ensure heterodimerization during expression in mammalian cells, we introduced complementary k  ...[more]

Similar Datasets

| S-EPMC8656063 | biostudies-literature
| S-EPMC25279 | biostudies-literature
| S-EPMC4661895 | biostudies-literature
| S-EPMC7118043 | biostudies-literature
| S-EPMC5220356 | biostudies-literature
| S-EPMC6609762 | biostudies-literature
| 2272861 | ecrin-mdr-crc
| S-EPMC8172155 | biostudies-literature
| S-EPMC1143638 | biostudies-literature
| S-EPMC5582862 | biostudies-literature